These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1998 Jan 30; 47(RR-2):1-30. PubMed ID: 9461044 [Abstract] [Full Text] [Related]
3. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Mofenson LM, Centers for Disease Control and Prevention, U.S. Public Health Service Task Force. MMWR Recomm Rep; 2002 Nov 22; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844 [Abstract] [Full Text] [Related]
5. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V. N Engl J Med; 2000 Oct 05; 343(14):982-91. PubMed ID: 11018164 [Abstract] [Full Text] [Related]
6. [Decision guides for antiretroviral treatment in pregnancy]. Malinverni R, Rudin C. Ther Umsch; 1998 May 05; 55(5):323-8. PubMed ID: 9643130 [Abstract] [Full Text] [Related]
15. No adverse effects in infants following short-course zidovudine. AIDS Read; 2001 Feb 01; 11(2):81. PubMed ID: 11279877 [No Abstract] [Full Text] [Related]